145 related articles for article (PubMed ID: 33162112)
1. A systematic review with in silico analysis on transcriptomic profile of gallbladder carcinoma.
Tulsyan S; Hussain S; Mittal B; Saluja SS; Tanwar P; Rath GK; Goodman M; Kaur T; Mehrotra R
Semin Oncol; 2020 Dec; 47(6):398-408. PubMed ID: 33162112
[TBL] [Abstract][Full Text] [Related]
2. Identification of microRNAs associated with the survival of patients with gallbladder carcinoma.
Wang J; Jin Y; Li S; Song Q; Tang P
J Int Med Res; 2020 May; 48(5):300060520918061. PubMed ID: 32406793
[TBL] [Abstract][Full Text] [Related]
3. In silico analysis unveiling potential biomarkers in gallbladder carcinogenesis.
Gupta RK; Bhushan R; Kumar S; Prasad SB
Sci Rep; 2024 Jun; 14(1):14570. PubMed ID: 38914609
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA aberrations: An emerging field for gallbladder cancer management.
Chandra V; Kim JJ; Mittal B; Rai R
World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
[TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of long non-coding RNA in gallbladder cancer pathogenesis.
Khandelwal A; Malhotra A; Jain M; Vasquez KM; Jain A
Biochimie; 2017 Jan; 132():152-160. PubMed ID: 27894946
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of gallbladder cancer: An update.
Mishra SK; Kumari N; Krishnani N
Mutat Res; 2019 Nov; 816-818():111674. PubMed ID: 31330366
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive narrative review of transcriptomics and epigenomics of gallbladder cancer.
Tanwar P; Minocha S; Gupta I
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S499-S507. PubMed ID: 38384011
[TBL] [Abstract][Full Text] [Related]
9. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.
Alvarez H; Corvalan A; Roa JC; Argani P; Murillo F; Edwards J; Beaty R; Feldmann G; Hong SM; Mullendore M; Roa I; Ibañez L; Pimentel F; Diaz A; Riggins GJ; Maitra A
Clin Cancer Res; 2008 May; 14(9):2631-8. PubMed ID: 18451226
[TBL] [Abstract][Full Text] [Related]
10. Unravelling of the comparative Transcriptomic Profile of Gallbladder Cancer using mRNA sequencing.
Dixit R; Pandey M; Rajput M; Shukla VK
Mol Biol Rep; 2022 Jul; 49(7):6395-6403. PubMed ID: 35469389
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA signatures in total peripheral blood of gallbladder cancer patients.
Li G; Pu Y
Tumour Biol; 2015 Sep; 36(9):6985-90. PubMed ID: 25861754
[TBL] [Abstract][Full Text] [Related]
12. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p.
Goeppert B; Truckenmueller F; Ori A; Fritz V; Albrecht T; Fraas A; Scherer D; Silos RG; Sticht C; Gretz N; Mehrabi A; Bewerunge-Hudler M; Pusch S; Bermejo JL; Dietrich P; Schirmacher P; Renner M; Roessler S
Sci Rep; 2019 Mar; 9(1):4796. PubMed ID: 30886199
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review.
Montalvo-Jave EE; Rahnemai-Azar AA; Papaconstantinou D; Deloiza ME; Tsilimigras DI; Moris D; Mendoza-Barrera GE; Weber SM; Pawlik TM
Surg Oncol; 2019 Dec; 31():83-89. PubMed ID: 31541911
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
[TBL] [Abstract][Full Text] [Related]
15. GBCdb: RNA expression landscapes and ncRNA-mRNA interactions in gallbladder carcinoma.
Guo L; Xiang Y; Dou Y; Yin Z; Xu X; Tang L; Yu J; Wang J; Liang T
BMC Bioinformatics; 2023 Jan; 24(1):12. PubMed ID: 36624399
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.
Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z
Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628
[TBL] [Abstract][Full Text] [Related]
17. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease.
Sharma P; Bhunia S; Poojary SS; Tekcham DS; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK
Tumour Biol; 2016 Nov; 37(11):14687-14699. PubMed ID: 27623942
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells.
Lin N; Yao Z; Xu M; Chen J; Lu Y; Yuan L; Zhou S; Zou X; Xu R
J Exp Clin Cancer Res; 2019 Jun; 38(1):244. PubMed ID: 31174563
[TBL] [Abstract][Full Text] [Related]
19. Decoding the role of long non-coding RNAs in gallbladder cancer pathogenesis: A review focus on signaling pathways interplay.
Doghish AS; Radwan AF; Zaki MB; Elfar N; Moussa R; Walash Z; Alhamshry NAA; Mohammed OA; Abdel-Reheim MA; Elimam H
Int J Biol Macromol; 2024 Apr; 264(Pt 1):130426. PubMed ID: 38428766
[TBL] [Abstract][Full Text] [Related]
20. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes.
Nepal C; Zhu B; O'Rourke CJ; Bhatt DK; Lee D; Song L; Wang D; Van Dyke AL; Choo-Wosoba H; Liu Z; Hildesheim A; Goldstein AM; Dean M; LaFuente-Barquero J; Lawrence S; Mutreja K; Olanich ME; Lorenzo Bermejo J; ; Ferreccio C; Roa JC; Rashid A; Hsing AW; Gao YT; Chanock SJ; Araya JC; Andersen JB; Koshiol J
J Hepatol; 2021 May; 74(5):1132-1144. PubMed ID: 33276026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
